Literature DB >> 31462576

Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity.

Chelsea Gerada1, Megan Steain1, Tessa Mollie Campbell1, Brian McSharry1, Barry Slobedman1, Allison Abendroth2.   

Abstract

Immune regulation of alphaherpesvirus latency and reactivation is critical for the control of virus pathogenesis. This is evident for herpes simplex virus 1 (HSV-1), where cytotoxic T lymphocytes (CTLs) prevent viral reactivation independent of apoptosis induction. This inhibition of HSV-1 reactivation has been attributed to granzyme B cleavage of HSV infected cell protein 4 (ICP4); however, it is unknown whether granzyme B cleavage of ICP4 can directly protect cells from CTL cytotoxicity. Varicella zoster virus (VZV) is closely related to HSV-1; however, it is unknown whether VZV proteins contain granzyme B cleavage sites. Natural killer (NK) cells play a central role in VZV and HSV-1 pathogenesis and, like CTLs, utilize granzyme B to kill virally infected target cells. However, whether alphaherpesvirus granzyme B cleavage sites could modulate NK cell-mediated cytotoxicity has yet to be established. This study aimed to identify novel HSV-1 and VZV gene products with granzyme B cleavage sites and assess whether they could protect cells from NK cell-mediated cytotoxicity. We have demonstrated that HSV ICP27, VZV open reading frame 62 (ORF62), and VZV ORF4 are cleaved by granzyme B. However, in an NK cell cytotoxicity assay, only VZV ORF4 conferred protection from NK cell-mediated cytotoxicity. The granzyme B cleavage site in ORF4 was identified via site-directed mutagenesis and, surprisingly, the mutation of this cleavage site did not alter the ability of ORF4 to modulate NK cell cytotoxicity, suggesting that ORF4 has a novel immunoevasive function that is independent from the granzyme B cleavage site.IMPORTANCE HSV-1 causes oral and genital herpes and establishes life-long latency in sensory ganglia. HSV-1 reactivates multiple times in a person's life and can cause life-threatening disease in immunocompromised patients. VZV is closely related to HSV-1, causes chickenpox during primary infection, and establishes life-long latency in ganglia, from where it can reactivate to cause herpes zoster (shingles). Unlike HSV-1, VZV only infects humans, and there are limited model systems; thus, little is known concerning how VZV maintains latency and why VZV reactivates. Through studying the link between immune cell cytotoxic functions, granzyme B, and viral gene products, an increased understanding of viral pathogenesis will be achieved.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Herpes simplex virus (HSV); Varicella zoster virus (VZV); granzyme B; natural killer (NK) cells

Year:  2019        PMID: 31462576      PMCID: PMC6819919          DOI: 10.1128/JVI.01140-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.

Authors:  Tessa M Campbell; Brian P McSharry; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

2.  Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia.

Authors:  Megan Steain; Jeremy P Sutherland; Michael Rodriguez; Anthony L Cunningham; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

3.  Adenovirus L4-100K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death.

Authors:  F Andrade; H G Bull; N A Thornberry; G W Ketner; L A Casciola-Rosen; A Rosen
Journal:  Immunity       Date:  2001-06       Impact factor: 31.745

4.  Varicella-zoster virus ORF4 latency-associated protein is important for establishment of latency.

Authors:  Jeffrey I Cohen; Tammy Krogmann; Jeffrey P Ross; Lesley Pesnicak; Elena A Prikhod'ko
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses.

Authors:  Nandini Sen; Marvin Sommer; Xibing Che; Kris White; William T Ruyechan; Ann M Arvin
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

6.  Herpes simplex virus ICP27 increases translation of a subset of viral late mRNAs.

Authors:  Errin C Fontaine-Rodriguez; David M Knipe
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

7.  Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia.

Authors:  Georges M G M Verjans; Rogier Q Hintzen; Jessica M van Dun; Angelique Poot; Johannes C Milikan; Jon D Laman; Anton W Langerak; Paul R Kinchington; Albert D M E Osterhaus
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

8.  Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation.

Authors:  V R Sutton; J E Davis; M Cancilla; R W Johnstone; A A Ruefli; K Sedelies; K A Browne; J A Trapani
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

9.  Distinct Migration and Contact Dynamics of Resting and IL-2-Activated Human Natural Killer Cells.

Authors:  Per E Olofsson; Elin Forslund; Bruno Vanherberghen; Ksenia Chechet; Oscar Mickelin; Alexander Rivera Ahlin; Tobias Everhorn; Björn Onfelt
Journal:  Front Immunol       Date:  2014-03-07       Impact factor: 7.561

Review 10.  The suppression of apoptosis by α-herpesvirus.

Authors:  Yu You; An-Chun Cheng; Ming-Shu Wang; Ren-Yong Jia; Kun-Feng Sun; Qiao Yang; Ying Wu; Dekang Zhu; Shun Chen; Ma-Feng Liu; Xin-Xin Zhao; Xiao-Yue Chen
Journal:  Cell Death Dis       Date:  2017-04-13       Impact factor: 8.469

View more
  5 in total

1.  Pseudorabies Virus Infection Causes Downregulation of Ligands for the Activating NK Cell Receptor NKG2D.

Authors:  Sofie Denaeghel; Steffi De Pelsmaeker; Cliff Van Waesberghe; Herman W Favoreel
Journal:  Viruses       Date:  2021-02-09       Impact factor: 5.048

Review 2.  Oxidative and Non-Oxidative Antimicrobial Activities of the Granzymes.

Authors:  Marilyne Lavergne; Maria Andrea Hernández-Castañeda; Pierre-Yves Mantel; Denis Martinvalet; Michael Walch
Journal:  Front Immunol       Date:  2021-10-11       Impact factor: 7.561

3.  Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinoma.

Authors:  Tiangen Wu; Yang Ke; Haoran Tang; Chen Liao; Jinze Li; Lin Wang
Journal:  Mol Ther Oncolytics       Date:  2021-06-12       Impact factor: 7.200

Review 4.  Non-cytotoxic functions of CD8 T cells: "repentance of a serial killer".

Authors:  Mouhamad Al Moussawy; Hossam A Abdelsamed
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

Review 5.  Emerging Canonical and Non-Canonical Roles of Granzyme B in Health and Disease.

Authors:  Ellis Tibbs; Xuefang Cao
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.